# Ironwood Pharmaceuticals, Inc. (IRWD): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Ironwood Pharmaceuticals, Inc. (IRWD) is 99/100, ranked against 24,000+ stocks in 35 markets (Quality 86, Value 76, Momentum 61, each scored against its sector).

- StockRank: 99/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 86, Value 76, Momentum 61: each a 0-100 percentile within the stock's sector.
- Position: #203 overall, #32 in Healthcare.
- Listing: United States, NMS; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 3.76 USD on 12 Oct 2026.
- Insider filings, last 180 days: directors sold USD 659K.

Source: https://moatmap.ai/stock/IRWD
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker